Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03794349 |
|---|---|
| Brief Title: | Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma |
| First Submitted : | January 2, 2019 |
| First Submitted that Met QC Criteria : | January 3, 2019 |
| First Posted : | January 7, 2019 |
| Last Update Submitted that Met QC Criteria : | April 18, 2024 |
| Last Update Posted : | April 22, 2024 |